NHS England
London, SE1 8UG, United Kingdom
NCT Number: NCT05993260
This study is a nationwide randomised controlled trial (RCT) to test the impact of behavioural science-informed text messages notifying patients of their eligibility for the COVID-19 vaccine on vaccination rates.
Looking for future studies?
Notify Me40 year–44 year
All sexes
Interventional
Not applicable
London, SE1 8UG, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Behaviourally-informed content in vaccination eligibility reminder text messages
Control vaccination eligibility reminder text message
Time frame: 72 hours
The proportion of first dose vaccination appointments booked through the NHS National Booking System within 72 hours (inclusive) of the text message being sent
Time frame: 14 days
The proportion of first dose vaccinations received within 14 days (inclusive) of the text message being sent
The Behavioural Insights Team
Other
Using Text Messages to Boost COVID-19 Vaccination Appointment Booking and Vaccination Rates: A Randomised Controlled Field Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06603090
Behavior, COVID-19
Itasca, Illinois, United States
View Trial DetailsNCT06832670
Adherence Interventions, Adolescent Health
Kahramanmaraş, Eyalet/Yerleşke, Turkey (Türkiye)
View Trial DetailsNCT07172074
Behavior, Health Behavior
Iowa City, Iowa, United States
View Trial DetailsNCT05977192
Behavior, Health Behavior
Oklahoma City, Oklahoma, United States
View Trial Details